speb/financial-data huggingface dataset:
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1030600000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 225100000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 47100000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 6122000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 6122000.00
VENUSREM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -9500000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Research And Development: 180800000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Research And Development: 46900000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 78927000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 78927000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2152661000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2152661000.00
VENUSREM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 16300000.00
VENUSREM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2000000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 657429000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1071600000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 370600000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 13366988.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 13366988.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 99100000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5609496000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5609496000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4562248000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4562248000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 36579518.24
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Tax Provision: 265100000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 100400000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.37
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 184603000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 184603000.00
VENUSREM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -149200000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 7157215000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 7157215000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 5609496000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5609496000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 16925000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 16925000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5609496000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5609496000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Total Expenses: 6068600000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1706800000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1547719000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1547719000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2640048000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2640048000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 184833000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 184833000.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 99100000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 99100000.00
VENUSREM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 130920000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 130920000.00
VENUSREM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 3154281000.00
VENUSREM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 3154281000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 538300000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1371800000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 13370474.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 7.18
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 741500000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 61800000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 61800000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 13370474.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 7.18
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 96000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — EBIT: 126100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 187900000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 233500000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 630300000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Income: 96000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 96000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 95900000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 96000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 96000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 95900000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 187900000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 96000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 92000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1371800000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 34100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 126000000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 741500000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 61800000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Research And Development: 39900000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 233500000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 30100000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1279800000.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 606500000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1927500000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 978800000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 965700000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 67300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 13366534.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 15.06
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 130400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 133700000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 219900000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2361900000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 133700000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5943100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 340100000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1073100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 4856900000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 13000000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 13400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 26400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1430500000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 22600000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 61700000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 61700000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 13366534.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 15.06
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — EBIT: 265000000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 326700000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 271600000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 994100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1720700000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 854400000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 100000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1066700000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5956500000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 67300000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 117400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 117400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 31900000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Income: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -100000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1720700000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4949000000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 158100000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 326700000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 201300000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 247900000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1927500000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 13366988.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 369200000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 25500000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 5809400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 42000000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 17100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1380600000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2142000000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 978800000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 264900000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1073100000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 61700000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Research And Development: 43500000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 271600000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 13366988.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5943100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4949000000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 63600000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 93400000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 7681000000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5943100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 143800000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5943100000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1679600000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1737900000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2824100000.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 307400000.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
VENUSREM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 3426400000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 630500000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1802600000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 13364681.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 19.14
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 862500000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 65600000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 65600000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 13364681.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 19.14
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — EBIT: 334800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 400400000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 309300000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 940100000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 100000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 100000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Income: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -100000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -100000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 400400000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 255800000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 309600000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1802600000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 25200000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 334700000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 862500000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 65600000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Research And Development: 47300000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 309300000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 78900000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1493000000.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
VENUSREM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 2607200000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 831800000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 7696000000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2594000000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1134900000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1134900000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1032800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1032800000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1715600000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1715600000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 13367148.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 13366169.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Basic EPS: 76.89
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 35.53
VENUSREM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 575200000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -377000000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 124100000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 124100000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 133700000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 133700000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 251200000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 251200000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1039400000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1039400000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -220800000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 599200000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 375200000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -289200000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 133700000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 133700000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6637500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6637500000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 513600000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 513600000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 3872700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1195600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 3952000000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3952000000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 13600000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 13600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 13600000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 13600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1617600000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1617600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 43200000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 43200000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Depreciation: 256700000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 256700000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 256700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 67600000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 256700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 67600000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 13367148.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 13366169.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Diluted EPS: 76.89
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 35.53
VENUSREM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1027800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 474900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — EBIT: 1342000000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — EBIT: 616200000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — EBITDA: 1598700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 683800000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -34900000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 251100000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -31200000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1180700000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -59400000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 6200000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1282000000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 467600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 939800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 939800000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 1889800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1889800000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Gross Profit: 3823300000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1398400000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Interest Expense: 400000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 100000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 400000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 100000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -5900000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 21400000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Inventory: 1293700000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1293700000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 6637500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6637500000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1815700000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1715600000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1715600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 110500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 110500000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 110500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 110500000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -16900000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 28100000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 28100000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Income: 1027800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Income: 474900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1027800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 474900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1032900000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 475000000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1027800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 474900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1027800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 474900000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1341500000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1032900000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 475000000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -400000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -100000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1466200000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -16900000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -16900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -400000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -100000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 4200000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 1889800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1889800000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -375100000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5697700000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5697700000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 143400000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 143400000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1598700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 683800000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Normalized Income: 1027800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 474900000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1557700000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Operating Income: 1216100000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 566600000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 7696000000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2594000000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 13366988.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 13366988.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 504300000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 504300000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 20800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 20800000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6503800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6503800000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -19800000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 39800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 39800000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: -100000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: -100000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 125800000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 49500000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 1376200000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1376200000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 788200000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 788200000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Payables: 1134900000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1134900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Pretax Income: 1341600000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 616100000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: 0.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1525600000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -377000000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 3872700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1195600000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 256700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 67600000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -16900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Research And Development: 181700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Research And Development: 51000000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 59400000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 1282000000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 467600000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 13366988.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 13366988.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 6637500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6637500000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 5697700000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5697700000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Tax Provision: 308700000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 141100000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 81800000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 81800000.00
VENUSREM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -342700000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 8537000000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 8537000000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 6637500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6637500000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 124100000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 124100000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 6637500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6637500000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Total Expenses: 6479900000.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2027400000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1899500000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1899500000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 4585000000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4585000000.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 281900000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 281900000.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
VENUSREM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
VENUSREM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 2334400000.00
VENUSREM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2334400000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 671600000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 1788600000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 13370198.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 17.18
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 842800000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 67700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 67700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 13370198.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 17.18
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — EBIT: 300400000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — EBITDA: 368100000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — General And Administrative Expense: 323500000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 945800000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Income: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 368100000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 229700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Operating Income: 274200000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 1788600000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 26200000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 300400000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 842800000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 67700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Research And Development: 46700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Selling General And Administration: 323500000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Special Income Charges: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 70700000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.24
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 1514400000.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: 0.00
VENUSREM.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 0.00
VEON cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 194000000.00
VEON cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 194000000.00
VEON cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 27000000.00
VEON cash_flow (annual, 2021-12-31) — Cash Dividends Paid: 0.00
VEON cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -259000000.00
VEON cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: 0.00
VEON income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 27000000.00
VEON cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -296000000.00
VEON cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: -113000000.00
VEON income_statement (annual, 2022-12-31) — +Operating Expense: 2282000000.00
VEON income_statement (annual, 2022-12-31) — +Total Revenue: 3755000000.00
VEON balance_sheet (annual, 2022-12-31) — Accounts Payable: 1087000000.00
VEON balance_sheet (annual, 2022-12-31) — Accounts Receivable: 446000000.00
VEON balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3979000000.00
VEON balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 12753000000.00
VEON balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -84000000.00
VEON income_statement (annual, 2022-12-31) — Amortization: 221000000.00
VEON cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 221000000.00
VEON cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 221000000.00
VEON income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 221000000.00
VEON cash_flow (annual, 2022-12-31) — Asset Impairment Charge: -107000000.00
VEON balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 5792000000.00
VEON income_statement (annual, 2022-12-31) — Basic Average Shares: 70120000.00
VEON income_statement (annual, 2022-12-31) — Basic EPS: -2.25
VEON cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2239000000.00
VEON cash_flow (annual, 2022-12-31) — Capital Expenditure: -1010000000.00
VEON balance_sheet (annual, 2022-12-31) — Capital Stock: 2000000.00
VEON balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3107000000.00
VEON balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 3227000000.00
VEON cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
VEON balance_sheet (annual, 2022-12-31) — Cash Equivalents: 2179000000.00
VEON balance_sheet (annual, 2022-12-31) — Cash Financial: 928000000.00
VEON cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 456000000.00
VEON cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1057000000.00
VEON cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 933000000.00
VEON cash_flow (annual, 2022-12-31) — Cash Flow From Discontinued Operation: -54000000.00
VEON cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: -340000000.00
VEON cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: -599000000.00
VEON cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 1624000000.00
VEON cash_flow (annual, 2022-12-31) — Change In Inventory: -12000000.00
VEON cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 48000000.00
VEON cash_flow (annual, 2022-12-31) — Change In Payable: 52000000.00
VEON cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 52000000.00
VEON cash_flow (annual, 2022-12-31) — Change In Receivables: -154000000.00
VEON cash_flow (annual, 2022-12-31) — Change In Working Capital: -66000000.00
VEON cash_flow (annual, 2022-12-31) — Changes In Cash: 963000000.00
VEON balance_sheet (annual, 2022-12-31) — Common Stock: 2000000.00
VEON cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
VEON balance_sheet (annual, 2022-12-31) — Common Stock Equity: 569000000.00
VEON cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
VEON balance_sheet (annual, 2022-12-31) — Construction In Progress: 286000000.00
VEON income_statement (annual, 2022-12-31) — Cost Of Revenue: 476000000.00
VEON balance_sheet (annual, 2022-12-31) — Current Assets: 9773000000.00
VEON balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2844000000.00
VEON balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 159000000.00
VEON balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 159000000.00
VEON balance_sheet (annual, 2022-12-31) — Current Liabilities: 8877000000.00
VEON balance_sheet (annual, 2022-12-31) — Current Provisions: 59000000.00
VEON cash_flow (annual, 2022-12-31) — Depreciation: 671000000.00
VEON cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 671000000.00
VEON income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 778000000.00
VEON cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 671000000.00
VEON income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 778000000.00
VEON income_statement (annual, 2022-12-31) — Depreciation Income Statement: 557000000.00
VEON income_statement (annual, 2022-12-31) — Diluted Average Shares: 70134267.00